Derek Small
Director/Board Member at INNOVIVA, INC.
Profile
Derek A.
Small is the founder of Luson Bioventures LLC, founded in 2007, where he holds the title of President.
He was also the founder of Assembly Pharmaceuticals, Inc., founded in 2012, where he held the title of Executive Chairman & Chief Executive Officer.
In 2014, he founded Assembly Biosciences, Inc., where he served as a Director from 2019 to 2020.
In 2018, he founded Gate Neurosciences, Inc., where he holds the title of Executive Chairman.
Currently, Mr. Small is a Director at Anagin, Inc. He is also an Independent Director at Innoviva, Inc. since 2024 and a Board Member at BioCrossroads since 2017.
Mr. Small has previously worked as an Advisor & CEO at EndGenitor Technologies, Inc. from 2007 to 2009.
He was the President, Chief Executive Officer & Director at Naurex, Inc. from 2012 to 2014.
From 2008 to 2011, he served as the Founding CEO & President at BlinkBio, Inc. and from 2009 to 2012, he was the President, Chief Executive Officer & Director at BlinkBio, Inc. He has also held positions as Director-Strategic Alliances at Simdesk Technologies, Inc. and Head-Business Development & Regulatory Affairs at Semafore Pharmaceuticals, Inc. Additionally, he has worked as an Advisor at Kinagen, Inc.Mr. Small's education includes an undergraduate degree from Franklin College Switzerland in 1998.
He also attended Franklin College of Indiana, Inc. and Harlaxton College for his undergraduate studies.
Derek Small active positions
| Companies | Position | Start |
|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 2024-04-28 |
Luson Bioventures LLC
 Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Founder | 2006-12-31 |
Gate Neurosciences, Inc.
 Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Founder | 2018-11-20 |
BioCrossroads
 BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Director/Board Member | 2017-06-30 |
Anagin, Inc.
 Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Director/Board Member | - |
Former positions of Derek Small
| Companies | Position | End |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Chief Executive Officer | 2019-08-05 |
BlinkBio, Inc.
 BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Chief Executive Officer | 2012-03-31 |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Chief Executive Officer | 2011-06-29 |
EndGenitor Technologies, Inc.
 EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Chief Executive Officer | 2009-03-20 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Derek Small
| Franklin College of Indiana, Inc. | Undergraduate Degree |
| Harlaxton College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Semafore Pharmaceuticals, Inc.
 Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
Simdesk Technologies, Inc.
 Simdesk Technologies, Inc. Packaged SoftwareTechnology Services SimDesk Technologies, Inc. provided web based software solutions and services. Its software products were used for desktop applications such as word processing, spreadsheets, printing, and e-mail management. The firm offered services to the government agencies and educational institutions. The company was founded by Ray C. Davis in 1999 and was headquartered in Houston, TX. | Technology Services |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Health Technology |
Luson Bioventures LLC
Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Finance |
| Kinagen, Inc. | |
Assembly Pharmaceuticals, Inc.
 Assembly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Assembly Pharmaceuticals, Inc. manufactures and supplies biopharmaceutical products. The company was founded on August 8, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Gate Neurosciences, Inc.
Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Health Technology |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Finance |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Health Technology |
Anagin, Inc.
Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- Derek Small